INVO Bioscience stock stays near its yearly range

Published on 09/23/2026 at 02:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

INVO Bioscience stock traded at USD 1.18 on September 22, 2026, within a projected USD 1.00 to USD 1.38 range. The company remains a fertility care name.

INVO, US44984F1049, Illustration mit AI erstellt.

INVO Bioscience Inc. (ISIN US44984F1049) traded at USD 1.18 on September 22, 2026, according to the available market snapshot. The quoted 2026 range runs from USD 1.00 to USD 1.38, placing the price USD 0.18 above the lower end and USD 0.20 below the upper end.

Price range defines the setup

The USD 1.18 level is a market figure dated September 22, 2026, while the USD 1.00 to USD 1.38 range is a forecast corridor for September 2026 rather than a reported operating result. That distinction matters because a projected trading band does not measure revenue, earnings or cash generation.

The available market material identifies the business under the INVO Fertility name and places the September 2026 average forecast at USD 1.18, with a stated monthly change of 36.32 percent. Those figures are model outputs, not company guidance, and therefore do not establish a fundamental valuation.

Operating figures require a dated report

For the stock, the next useful checkpoint is a company report that names its reporting period and provides revenue, operating income, net income or cash flow. Without a period-specific result in the available evidence, the USD 1.18 market level and the USD 1.00 to USD 1.38 forecast corridor remain the clearest dated figures for this article.

The company identity is tied to fertility care, but a business description alone cannot substitute for a current quarterly or annual figure. A comparison between the September average forecast of USD 1.18 and the USD 1.00 minimum gives a USD 0.18 spread, while the USD 1.38 maximum is USD 0.20 above that average.

Stock remains tied to forecast range

INVO Bioscience stock was valued at USD 1.18 on September 22, 2026. The same dated forecast placed September 2026 between USD 1.00 and USD 1.38, giving investors a defined numerical range while reported fundamentals remain the decisive next evidence point.